Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
13,941,085
-
Share change
-
+12,699,993
-
Total reported value
-
$154,332,082
-
Price per share
-
$11.37
-
Number of holders
-
40
-
Value change
-
+$140,835,971
-
Number of buys
-
30
-
Number of sells
-
9
Institutional Holders of HARPOON THERAPEUTICS INC - COM NEW (HARP) as of Q4 2023
As of 31 Dec 2023,
HARPOON THERAPEUTICS INC - COM NEW (HARP) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,941,085 shares.
The largest 10 holders included
Cormorant Asset Management, LP, COMMODORE CAPITAL LP, RA CAPITAL MANAGEMENT, L.P., FRANKLIN RESOURCES INC, Artal Group S.A., VANGUARD GROUP INC, Soleus Capital Management, L.P., Blackstone Inc., CITADEL ADVISORS LLC, and Ally Bridge Group (NY) LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.